OTC Watch

All stocks / CPMV

Mosaic ImmunoEngineering Inc. CPMV

Mosaic ImmunoEngineering (CPMV): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float Pink LimitedCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
MOSAIC IMMUNOENGINEERING INC
Market tier
OTC Pink Limited
Trading status
Active
Last trade
Nov 13
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($687,846)
What it means

It spends more than it earns

Under strain

The company lost $687,846 in the year. It reported no sales.

The report says
Cash and cash equivalents
$3,622
Net cash used in operating activities
($111,397)
What it means

The cash could run out soon

Under strain

It had $3,622 in the bank and used about $9,283 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$19,882
Total liabilities
$7,495,902
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $19,882. Its debts and unpaid bills add up to $7.5 million. That is about $377.02 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-11-16

Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-08-14

Estimated float about 7,242,137 shares as of 2026-08-14: 7,242,137 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-05-15

Filed NT 10-Q on 2026-05-15: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-09-30
7.2M
2025-11-19
7.2M
2025-12-31
7.2M
2026-03-31
7.2M
2026-04-15
7.2M
2026-05-20
7.2M
2026-06-30
7.2M
2026-08-14
7.2M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 NT 10-QEXTENSION
2026-08-14 10-QFORM 10-Q FOR JUN 2026
2026-05-20 10-QFORM 10-Q FOR MAR 2026
2026-05-15 NT 10-Q10-Q EXTENSION FOR MARCH 2026
2026-04-15 10-KFORM 10-K FOR DEC 2025
2026-03-31 NT 10-KNOTICE OF LATE FILING
2025-11-19 10-QFORM 10-Q FOR SEPT 2025

Common questions about CPMV

Does CPMV file reports with the SEC?

Yes. Mosaic ImmunoEngineering files with the SEC under company number 0000836564. The most recent filing we hold is a NT 10-Q dated 2026-11-16.

Source record

How many CPMV shares are outstanding?

7,242,137 shares as of 2026-08-14, as reported to the SEC.

Source record

Has CPMV filed reports late?

Yes. In the last 12 months it filed 3 late-filing notices, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Mosaic ImmunoEngineering making money?

The company lost $687,846 in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record